產(chǎn)品詳情
簡單介紹：
Anti-CIDEB抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-CIDEB抗體用于**組化實驗,WB實驗,相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-CIDEB
Cat. Number:
Anti-CIDEB抗體KL-0544R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Apoptosis is related to Anti-CIDEB抗體many diseases and induced by a family of cell death receptors and their ligands. Cell death signals are transduced by death domain containing adapter molecules and members of the caspase family of proteases. These death signals finally cause the degradation of chromosomal DNA by activated DNase. DFF45/ICAD has been identified as an inhibitor of caspase activated DNase DFF40/CAD. DFF45 related proteins CIDE A and CIDE B were recently identified. CIDE contains a new type of domain termed CIDE N, which has high homology with the regulatory domains of DFF45/ICAD and DFF40/CAD. Expression of CIDE B induces apoptosis, which is inhibited by DFF45. CIDE B is a DFF45 inhibitable effector that promotes cell death and DNA fragmentation. CIDE B is expressed mainly in liver and small intestine and at lower levels in spleen, Anti-CIDEB抗體colon, kidney, peripheral blood lymphocytes, and bone marrow.
Also known as:
cell death activator CIDE-B; cell death-inducing DFFA-like effector B; Cide-b; CIDEB_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, Anti-CIDEB抗體affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, .
●
Immunogen: KLH conjugated synthetic peptide derived from human CIDE-B C-terminus.
●
Predicted Molecular Weight: 24kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions Anti-CIDEB抗體must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions Anti-CIDEB抗體must be determined by the end user.
kl130Rb51 組織金屬蛋白酶抑制因子4(TIMP4)多克隆抗體 Polyclonal Antibody to Tissue Inhibitors Of Metalloproteinase 4 (TIMP4)
kl131Bo01 轉(zhuǎn)化生長因子β誘導(dǎo)蛋白(TGFβI)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)
kl131Fi01 轉(zhuǎn)化生長因子β誘導(dǎo)蛋白(TGFβI)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)
kl131Hu01 轉(zhuǎn)化生長因子β誘導(dǎo)蛋白(TGFβI)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)
kl131Mu01 轉(zhuǎn)化生長因子β誘導(dǎo)蛋白(TGFβI)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)
kl131Po01 轉(zhuǎn)化生長因子β誘導(dǎo)蛋白(TGFβI)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)
kl131Rb51 轉(zhuǎn)化生長因子β誘導(dǎo)蛋白(TGFβI)多克隆抗體 Polyclonal Antibody to Transforming Growth Factor Beta Induced Protein (TGFbI)
kl132Hu01 脂聯(lián)素受體2(ADIPOR2)多克隆抗體 Polyclonal Antibody to Adiponectin Receptor 2 (ADIPOR2)
kl132Ra01 脂聯(lián)素受體2(ADIPOR2)多克隆抗體 Polyclonal Antibody to Adiponectin Receptor 2 (ADIPOR2)
kl134Bo01 腫瘤壞死因子β(TNFβ)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Ca01 腫瘤壞死因子β(TNFβ)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Hu01 腫瘤壞死因子β(TNFβ)多克隆抗體 Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
